First clinical ablation cases in the EU using the Thermocool Smarttouch contact force sensing catheter

259

Following recent CE-marking, Biosense Webser announced the successful completion of the first clinical cases in the European Union with the new Thermocool Smarttouch contact force sensing catheter.

Paolo Della Bella from the San Raffaele Hospital in Milan, Italy, performed the first human cases with the Thermocool Smarttouch catheter and Carto 3 system. “This is a breakthrough technology. The additional force reading parameter gives me the confidence that improves my ablation procedure to better serve my patients’ symptoms and quality of life,” said Della Bella.

During cardiac ablation, the Thermocool Smarttouch catheter enables the measurement of catheter tip contact force and direction inside the heart. The force and contact information is graphically displayed on the Carto 3 mapping and navigation system with the Carto 3 Smarttouch software module thus creating the only fully integrated solution in the electrophysiology market which combines contact force, 3D mapping and navigation capabilities.

“Thermocool Smarttouch catheter brings important new force reading information to physicians when performing cardiac ablation, and will provide them with a new and important measure that can help further improve procedural outcomes. This breakthrough technology continues our commitment to bringing advanced tools to the Cardiac Electrophysiology community, so that they may better serve their patients,” said Shlomi Nachman, worldwide president, Biosense Webster.

(Visited 36 times, 1 visits today)